Pharmaceutical Product Monograph: Cephalothin Sodium (1 g, 2 g)
In the pharmaceutical industry, Cephalothin is a semi-synthetic, parenteral First-Generation Cephalosporin. As a pharmacist and manufacturer, I view this molecule as the “Original Beta-Lactam Reference”—it was technically the first cephalosporin to be marketed and remains a potent weapon against Gram-positive bacteria, particularly Staphylococci and Streptococci.
At your WHO-GMP facility in Mumbai, Cephalothin is a specialized SKU. While newer generations have broader Gram-negative coverage, Cephalothin remains technically superior for skin, soft tissue, and bone infections where Staph. aureus is the primary suspect.
Therapeutic Profile: Primary Indications
Cephalothin is indicated for the treatment of serious infections caused by susceptible organisms, primarily Gram-positive cocci.
| Indication | Clinical Context | Technical Rationale |
| Surgical Prophylaxis | Peri-operative | Gold Standard (Traditional): Used to prevent post-op infections in orthopedic, cardiac, and vascular surgeries. |
| Septicemia | Bloodstream Infection | Effective against Staphylococcus aureus (MSSA) and Streptococcus pyogenes in the blood. |
| Osteomyelitis | Bone Infection | Reaches high concentrations in bone tissue, making it ideal for treating infected fractures or joint replacements. |
| Endocarditis | Heart Valve Infection | Used in high-dose IV regimens to treat bacterial infections of the heart lining. |
| Skin & Soft Tissue | Severe Cellulitis | First-line parenteral choice for abscesses and complicated skin infections. |
Mechanism: Cell Wall Synthesis Disruption
Cephalothin works by sabotaging the structural integrity of the bacterial cell wall during its active growth phase:
PBP High Affinity: The drug binds with high affinity to Penicillin-Binding Proteins (PBPs) on the bacterial cell membrane.
Transpeptidation Blockade: It inhibits the final cross-linking of peptidoglycan strands, which provide the cell wall its mechanical strength.
Osmotic Lysis: Technically, this creates a “weak” cell wall. The internal osmotic pressure of the bacteria then causes the cell to swell and burst (Lysis), resulting in bacterial death.
The Pharmacist’s “Technical Warning”
The “Vein Irritation” Risk: As a pharmacist, I must emphasize that Cephalothin is highly irritating to the veins. It should technically be given via a large vein or diluted significantly to prevent thrombophlebitis (vein inflammation).
Renal Toxicity: While safer than older aminoglycosides, high doses of Cephalothin can be nephrotoxic, especially if combined with Loop Diuretics (like Furosemide). Monitor kidney function closely.
Penicillin Cross-Reactivity: There is a technical cross-sensitivity risk (approx. 5–10%) in patients with a history of Penicillin Anaphylaxis. Always perform a skin test before the first dose.
Half-Life: Cephalothin has a very short half-life (approx. 30–50 minutes), meaning it technically requires frequent dosing (every 4–6 hours) to maintain therapeutic levels.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Aseptic Crystallization” USP: On your digital marketplace, highlight your High-Purity Crystalline Sodium salt. Cephalothin is highly sensitive to moisture. Your Aseptic Powder Filling ensures a stable, white-to-off-white cake with a 24-month shelf life.
The “Bone Surgery” Niche: For international B2B tenders, market Cephalothin specifically to Orthopedic Surgical Centers. Its proven track record in bone penetration makes it a preferred “niche” antibiotic over generic ceftriaxone in these settings.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cephalothin 1 g and 2 g vials to support your registration in international B2B tenders for surgery and trauma care.